Torsemide
Sulfonamides, Plain
Sold as SOAANZ
- Drug class
- Sulfonamides, Plain
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 29
- FDA reports (12 mo)
- 2,808
Overview
Plain-language summary, compiled from the cited regulatory records
Torsemide is a medication classified as a sulfonamide diuretic [1]. It is approved for the treatment of edema, which is swelling caused by fluid retention, in individuals with heart failure, kidney disease, or liver disease [1]. Additionally, torsemide is used to manage hypertension, or high blood pressure [1]. By lowering blood pressure, it helps reduce the risk of serious cardiovascular events, such as strokes and heart attacks [1].
In the market, torsemide is available under various brand names, including SOAANZ [1]. Over the past 12 months, there have been 2,808 adverse event reports associated with this medication [2]. Common adverse events reported include shortness of breath, diarrhea, fatigue, cough, and nausea [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 20 | May 29, 2026 |
| US United States | FDA | 9 | March 26, 2026 |
GBUnited Kingdom· MHRA
20 products
Uses
Oedema due to congestive heart failure; hepatic, pulmonary or renal oedema.
How to take
USUnited States· FDA
9 products
Uses
1 INDICATIONS AND USAGE Torsemide is a loop diuretic indicated for: the treatment of edema associated with heart failure, renal disease or hepatic disease. 1 ) the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
1 Edema Torsemide tablets are indicated for the treatment of edema associated with heart failure, renal disease or hepatic disease. 2 Hypertension Torsemide tablets are indicated for the treatment of hypertension, to lower blood pressure.
Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs.
There are no controlled trials demonstrating risk reduction with torsemide. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake.
Drug interactions
Known interactions involving Torsemide. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 563. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL218800305 · revised November 7, 2025
- [2]FDA DailyMed · 03fbbb85-4e0f-4f… · revised June 30, 2023 [PDF]
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.